CF
TECH icon

Covea Finance’s Bio-Techne TECH Stock Holding History

Covea Finance’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-38,300
Closed -$2M – 162
2026
Q1 		$2M Hold
38,300
– – 0.07% 142
2025
Q4 		$2.25M Buy
+38,300
New +$2.33M 0.07% 124
2023
Q2 		– Sell
-44,000
Closed -$3.26M – 113
2023
Q1 		$3.26M Sell
44,000
-6,400
-13% -$493K 0.19% 83
2022
Q4 		$4.18M Sell
50,400
-7,600
-13% -$604K 0.21% 82
2022
Q3 		$4.12M Hold
58,000
– – 0.22% 82
2022
Q2 		$5.03M Sell
58,000
-10,892
-16% -$1.02M 0.7% 31
2022
Q1 		$7.46M Hold
68,892
– – 0.82% 28
2021
Q4 		$8.91M Buy
+68,892
New +$8.45M 0.78% 28

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Covea Finance's TECH Position: Q2 2026 in Review

Covea Finance sold out of Bio-Techne (TECH) in Q2 2026, closing a stake of 38,300 shares — an estimated $2M sold.

Covea Finance first reported a position in TECH in Q4 2021 and held it in 8 quarters. The position peaked at $8.91M in Q4 2021. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Covea Finance reported no remaining Bio-Techne position as of Q2 2026 after selling out during the quarter.
  • Covea Finance sold 38,300 Bio-Techne shares in Q2 2026, an estimated $2M.
  • Covea Finance first reported a position in Bio-Techne in Q4 2021 and held it in 8 quarters.
  • Covea Finance's Bio-Techne position peaked at $8.91M in Q4 2021.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Covea Finance's 13F filing for Q2 2026, filed 13 Jul 2026.